Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa

Investing in Justice: Ethics, Evidence, and the Eradication Investment Cases for Lymphatic Filariasis and Onchocerciasis

(2015) Theodore C. Bailey et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Can Economic Analysis Contribute to Disease Elimination and Eradication? A Systematic Review

(2015) Elisa Sicuri et al.   PLoS One

Control, Elimination, and Eradication of River Blindness: Scenarios, Timelines, and Ivermectin Treatment Needs in Africa

(2015) Young Eun Kim et al.   PLoS Neglected Tropical Diseases

Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases

(2013) P. Klepac et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

NTDs V.2.0: “Blue Marble Health”—Neglected Tropical Disease Control and Elimination in a Shifting Health Policy Landscape

(2013) Peter J. Hotez   PLoS Neglected Tropical Diseases

The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study

(2013) Hugo C. Turner et al.   PLoS Neglected Tropical Diseases

Developing Eradication Investment Cases for Onchocerciasis, Lymphatic Filariasis, and Human African Trypanosomiasis: Rationale and Main Challenges

(2013) Fabrizio Tediosi et al.   PLoS Neglected Tropical Diseases

Proof-of-Principle of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: Final Results of a Study in Mali and Senegal

(2012) Mamadou O. Traore et al.   PLoS Neglected Tropical Diseases

Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon

(2009) Samuel Wanji et al.   Parasites & Vectors

The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs gross-costing approaches

(2008) Fiona M. Clement (Nee Shrive) et al.   HEALTH ECONOMICS